Source comparison
Kisspeptin Side Effects: Comparison Across Peptide Classes
Kisspeptin-54 GnRH neuron activation → pulsatile LH/FSH release Injection site reactions (10–15%), transient headaches (5–8%), facial flushing (3–5%) 0% across 800+ trial participants Investigational (Phase 2) GnRH (gonadorelin) Direct GnRH receptor agonism Na
This comparison does not assign a generated winner or score.
- Kisspeptin-54
- GnRH neuron activation → pulsatile LH/FSH release
- Injection site reactions (10–15%), transient headaches (5–8%), facial flushing (3–5%)
- 0% across 800+ trial participants
- Investigational (Phase 2)
- GnRH (gonadorelin)
- Direct GnRH receptor agonism
- Nausea (20–30%), headache (15–25%), injection site pain (10–20%), ovarian hyperstimulation (IVF context: 5–10%)
- <1% (OHSS-related hospitalisation)
- FDA-approved (reproductive disorders)
- hCG (human chorionic gonadotropin)
- LH receptor agonism
- Injection site reactions (15–25%), headache (10–18%), mood changes (8–12%), gynecomastia in males (5–10% with chronic use)
- <1% (thromboembolic events, OHSS)
- FDA-approved (fertility, hypogonadism)
- Clomiphene citrate
- Selective estrogen receptor modulator → indirect GnRH stimulation
- Visual disturbances (1–5%), hot flashes (10–15%), mood swings (8–12%), ovarian enlargement (5–10%)
- <1% (ovarian torsion, stroke)
- FDA-approved (ovulation induction)
- Letrozole (off-label)
- Aromatase inhibition → reduced estrogen negative feedback
- Hot flashes (15–25%), joint pain (10–18%), fatigue (8–12%), bone density reduction (long-term)
- <1% (cardiovascular events)
- FDA-approved (breast cancer; off-label fertility)
- Kisspeptin's adverse event profile is the mildest in this comparison. No systemic toxicity, no downstream metabolic complications, and no organ-specific accumulation. The peptide does not cross-react with non-target receptors (unlike clomiphene, which affects estrogen receptors throughout the body), and it does not suppress endogenous hormone production after discontinuation (unlike synthetic GnRH analogs, which cause temporary hypogonadism during washout).